Literature DB >> 29295053

Tracking the Implementation of Electronic Medical Records in Dubai, United Arab Emirates, Using an Adoption Benchmarking Tool.

Osama El-Hassan1, Amer Sharif2, Mohammad Al Redha1, Iain Blair3.   

Abstract

In the United Arab Emirates (UAE), health services have developed greatly in the past 40 years. To ensure they continue to meet the needs of the population, innovation and change are required including investment in a strong e-Health infrastructure with a single transferrable electronic patient record. In this paper, using the Emirate of Dubai as a case study, we report on the Middle East Electronic Medical Record Adoption Model (EMRAM). Between 2011-2016, the number of participating hospitals has increased from 23 to 33. Currently, while 20/33 of hospitals are at Stage 2 or less, 10/33 have reached Stage 5. Also Dubai's median EMRAM score in 2016 (2.5) was higher than the scores reported from Australia (2.2), New Zealand (2.3), Malaysia (0.06), the Philippines (0.06) and Thailand (0.5). EMRAM has allowed the tracking of the progress being made by healthcare facilities in Dubai towards upgrading their information technology infrastructure and the introduction of electronic medical records.

Entities:  

Keywords:  Benchmarking; Electronic Health Records; Health Services

Mesh:

Year:  2017        PMID: 29295053

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Determinants predicting the electronic medical record adoption in healthcare: A SEM-Artificial Neural Network approach.

Authors:  Amina Almarzouqi; Ahmad Aburayya; Said A Salloum
Journal:  PLoS One       Date:  2022-08-16       Impact factor: 3.752

2.  Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial.

Authors:  Viktor V Chirikov; Chris Walker; Jennifer M Stephens; Patricia Schepman; Richard Chambers; Mahmoud Bakir; Gregory W Poorman; Seema Haider; Mohammed Farghaly
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.